Democratic Senator’s Illness Stalls Action on Drug Pricing Indefinitely

Sen. Ben Ray Lujan's (D-N.M.) recent stroke and absence makes it even less likely that Congress will pass Democratic drug pricing legislation any time soon.

Prospects for passage of Democratic drug pricing legislation as part of the Build Back Better (BBB) Act dimmed again last week with news that Sen. Ben Ray Lujan (D-N.M.) had a stroke on Jan 27.

Lujan’s chief of staff

Read More »

ICER Says Four Drugs Are Cost-Effective in Keeping COVID-19 Patients Out of Hospitals

The Institute for Clinical and Economic Review has tentatively concluded that four drugs have demonstrated effectiveness and value in reducing hospitalizations of COVID-19 patients.

The Institute for Clinical and Economic Review (ICER) has issued a draft report concluding four drugs have demonstrated effectiveness and value in reducing hospitalizations of COVID-19 patients. The independent nonprofit group evaluates prescription drugs and medical treatments’ cost effectiveness

Read More »

Scholarship Created in Memory of Long-Time 340B Leader Carl Taylor

The Carl Taylor Pharmacy Administration Scholarship at the University of North Carolina (UNC) Eshelman School of Pharmacy was announced this morning at the 340B Coalition Winter Conference in San Diego. Taylor, 76, the longtime pharmacy director at Piedmont Health Services in Chapel Hill, N.C., died last Sept. 24.

An endowed scholarship at the University of North Carolina (UNC) Eshelman School of Pharmacy has been established in memory of Carl Taylor, the longtime pharmacy director at Piedmont Health Services in Chapel Hill, N.C. Taylor, age 76, died last Sept.

Read More »

With Delta Variant Persisting, Health Care Groups Struggle with Conference Planning

Many health care organizations are reconsidering plans for in-person conferences as a result of the Delta variant. The 340B Coalition is polling potential attendees regarding their preferences for the its winter conference in late January.

After an initial burst of optimism earlier this year, some health care organizations are having second thoughts about large in-person events for the remainder of 2021 and the start of the new year.  However, some groups including the 340B Coalition

Read More »

In His First Public Comments, Ex-HHS Top Lawyer Stands by 340B Contract Pharmacy Advisory Opinion

Ex-HHS General Counsel Robert Charrow during a webinar yesterday defended his since-withdrawn 340B contract pharmacy advisory opinion.

Former U.S. Health and Human Services Department General Counsel Robert Charrow yesterday defended his strongly worded and colorful December 2020 advisory opinion, since vacated by a court and withdrawn by HHS, that the 340B statute unambiguously requires drug manufacturers to

Read More »

Divisions Among 340B Provider, Manufacturer, and Oncology Stakeholders on Stark Display During Webinar

Champions for 340B health centers and hospitals on one side and drug manufacturers and oncologists in private practice on the other faced off yesterday during a webinar on 340B hosted by STAT.

Champions for safety-net health care providers on one side and drug manufacturers and oncologists in private practice on the other faced off yesterday during a health care news service’s webinar on the 340B program.

The hour-long Sept. 15 webinar

Read More »

Sentry Data Systems Is the Latest 340B TPA to Change Hands

“Sentry looks forward to continuing to innovate and grow with its new partnership with Craneware," Sentry CEO Travis Leonardi said about his company's sale this week.

Healthcare data analytics company Craneware is buying 340B third-party administrator Sentry Data Systems, the latest in a series of 340B TPA acquisitions.

Abry Partners, the private equity firm that bought an approximately 89% stake in Sentry in May

Read More »

Health Centers Launch a New National Advocacy Group

Kerry Hydash (left) is Board Chair and Amanda Pears Kelly is Executive Director of the new health center group Advocates for Community Health.

Community health center leaders have created a new membership organization—Advocates for Community Health (ACH)—to influence federal health care policy and “drive a new vision for the role health centers can and should play in an evolving 21st century health care

Read More »

Grassroots Group Launches Regional Events to Promote 340B’s Importance

Community Voices for 340B (CV340B) promotes awareness of the 340B program through in-person seminars and webinars.

Community Voices for 340B (CV340B), the first non-profit grassroots organization focused on promoting the importance of the 340B program, kicked off the first of series of regional educational webinars scheduled last week. The event, which was focused on the Northeast

Read More »

HIV/AIDS Activists March To Protest AstraZeneca’s 340B Contract Pharmacy Cutbacks

HIV/AIDS Activists March To Protest AstraZeneca’s 340B Contract Pharmacy Cutbacks

Activists aligned with the powerful grassroots group AIDS Healthcare Foundation (AHF) marched yesterday in front of drug manufacturer AstraZeneca’s Wilmington, Del., headquarters building to protest the company’s decision effective Oct.

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live